COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,869 Articles (22,568 medRxiv, 8,301 bioRxiv)

Most recent first Previous |  Page 1144: Articles 11431-11440  | Next

Psychiatric Manifestations and Associated Risk Factors among Hospitalized Patients with COVID-19 in Edo State, Nigeria.
Okogbenin, E. O., Seb-Akahomen, O. J., Edeawe, O. I., Ehimigbai, M., Eboreime, H., Odike, A., Obagaye, M. O., Aweh, B. E., Erohubie, P., Eriyo, W., Inogbo, C. F., Akhideno, P., Eifediyi, G., Eifediyi, R., Asogun, D., Okogbenin, S. A.
10.1101/2021.10.12.21264913 — Posted: 2021-10-16
The role of educational settings in the transmission chain of SARS-CoV-2 in 2020: a systematic review
Vardavas, C., Nikitara, K., Mathioudakis, A., Hilton-Boon, M., Phalkey, R., Leonardi-Bee, J., Pharris, A., Deogan, C., Suk, J. E.
10.1101/2021.10.13.21264932 — Posted: 2021-10-16
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2
Di Fusco, M., Moran, M. M., Cane, A., Curcio, D., Khan, F., Malhotra, D., Surinach, A., Miles, A., Swerdlow, D., McLaughlin, J. M., Nguyen, J. L.
10.1101/2021.10.12.21264707 — Posted: 2021-10-16
Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids
Vanslambrouck, J. M., Wilson, S. B., Tan, K. S., Groenewegen, E., Rudraraju, R., Neil, J., Scurr, M., Howden, S. E., Subbarao, K., Little, M. H.
10.1101/2021.10.14.464320 — Posted: 2021-10-15
Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir
Götte, M., Gordon, C. J., Lee, H. W., Tchesnokov, E. P., Perry, J. K., Feng, J. Y., Bilello, J. P., Porter, D. P.
10.1101/2021.10.14.464416 — Posted: 2021-10-15
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
Johnson, B. A., Zhou, Y., Lokugamage, K. G., Vu, M. N., Bopp, N. E., Crocquet-Valdes, P. A., Schindewolf, C., Liu, Y., Scharton, D., Plante, J. A., Xie, X., Aguilar, P., Weaver, S., Shi, P.-Y., Walker, D. H., Routh, A. L., Menachery, V. D.
10.1101/2021.10.14.464390 — Posted: 2021-10-15
Opsonization by non-neutralizing antibodies can confer protection to SARS-CoV-2 despite Spike-dependent modulation of phagocytosis
Bahnan, W., Wrighton, S., Sundwall, M., Bläckberg, A., Larsson, O., Höglund, U., Khakzad, H., Godzwon, M., Walle, M., Elder, E., Happonen, L., Andre, O., Kumra Ahnlide, J., Hellmark, T., Wendel-Hansen, V., Wallin, R. P., Malmström, J., Malmström, L., Ohlin, M., Rasmussen, M., Nordenfelt, P.
10.1101/2021.10.14.464464 — Posted: 2021-10-15
Deep learning based on stacked sparse autoencoder applied to viral genome classification of SARS-CoV-2 virus
Coutinho, G. G. F., Camara, G. B. M., Barbosa, R. d. M., Fernandes, M. A. C.
10.1101/2021.10.14.464414 — Posted: 2021-10-15
Impact Of Adaptive Natural Killer Cells, KLRC2 Genotype And Cytomegalovirus Reactivation On Late Mortality In Patients With Severe Covid-19 Lung Disease
Jaiswal, S. R., Arunachalam, J., Bhardwaj, A., Saifullah, A., Lakhchaura, R., Soni, M., Bhagwati, G., Chakrabarti, S.
10.1101/2021.10.11.21264805 — Posted: 2021-10-14
Evaluation of real-life use of Point-Of-Care Rapid Antigen TEsting for SARS-CoV-2 in schools for outbreak control (EPOCRATES)
Blanchard, A. C., Desforges, M., Labbe, A.-C., Nguyen, C. T., Petit, Y., Besner, D., Zinszer, K., Seguin, O., Laghdir, Z., Adams, K., Benoit, M.-E., Leduc, G., Longtin, J., Ragoussis, I., Buckeridge, D. L., Quach, C.
10.1101/2021.10.13.21264960 — Posted: 2021-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).